Abstract

Osteoradionecrosis (ORN) is the most worrying radiotherapy late complication. It is a condition in which the irradiated bone becomes devitalized and exposed through fistulas in the skin or mucosa. It remains without healing for a period of at least three months. Despite being a well-known entity to the professionals who treat neoplasms of the head and neck, the disease has many controversies. From its classifications to its best treatment plan. Its main signs and symptoms are pain, drainage of secretion, fistulas, ulcers of the oral mucosa, bone exposure, bone necrosis, and the surrounding soft tissue. This study aims to report a clinical case of a patient with ORN in the jaw treated at Bahiana School of Medicine and Public Health and the General Roberto Santos Hospital. A 60-year-old-male patient with a malignant neoplasm in the tonsil region, was diagnosed with ORN in mandible region, three years after radiotherapy. The treatment proposal was conservative (ozone therapy, hyperbaric oxygen and chlorexidine mouth rinse) associated with surgical debridement, with good results that involved the patient’s rehabilitation. It is concluded that the association of conservative therapies with surgery demonstrated satisfactory results and improving the quality of life of cancer patients with ORN.

Highlights

  • More than eight million new cases of cancer occur worldwide

  • Despite the favorable results obtained with RT, late complications from this treatment may result in a decrease in the patients' quality of life

  • In 2010, he was diagnosed with malignant neoplasm in the tonsil region (T2N1M0), through a biopsy performed at Dom Pedro de Alcântara Hospital in Feira de Santana (BA)

Read more

Summary

Introduction

More than eight million new cases of cancer occur worldwide. Oral cancer corresponds for more than200,000 of these cases. More than eight million new cases of cancer occur worldwide. 10% of malignant tumors are head and neck cancer, and 90% of which are squamous cell carcinoma (dos Santos, et al, 2015; INCA, 2019). Head and neck cancer can affect several sites, with an average of 40%. Of cases occurring in the oral cavity, following 25% in the larynx, 15% in the pharynx, 7% in the salivary glands, and 13% in other regions. Chemotherapy (Ministério da Saúde, 2014; Store & Larheim, 1999).

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call